New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
07:50 EDTPCYCPharmacyclics volatility elevated at 71 on wide price movement
Pharmacyclics overall option implied volatility of 71 is above its 26-week average of 57 according to Track Data, suggesting large price movement.
News For PCYC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 1, 2015
09:10 EDTPCYCPharmacyclics initiates cancer study of ibrutinib with AstraZeneca's MEDI4736
Pharmacyclics (PCYC) initiated PCYC-1135-CA, a multi-center study that will investigate the use of ibrutinib in combination with MEDI4736, an investigational, anti-PD-L1 immune checkpoint inhibitor being developed by AstraZeneca (AZN). The Phase Ib/II study will examine the safety, tolerability and effectiveness of this investigational combination in individuals with relapsed or refractory non-small cell lung cancer, breast cancer, and pancreatic cancer. IMBRUVICA is jointly developed and commercialized by Pharmacyclics and Janssen Biotech.
March 30, 2015
07:24 EDTPCYCStifel to hold a bus tour
BioTrek: 2015 West Coast Healthcare Therapeutics Bus Tour travels throughout San Francisco on March 30-April 1.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use